MD Week

Duke University Medical Center, Durham - Aspirin reduces cardiovascular risks in men and women - but differently

Erasmus Medical Center, Rotterdam - Oral contraceptive pills influence phenotype expression in women with PCOS

Georgetown University Medical Center, Washington, DC - Commonly used antidepressants may also affect human immune system

Giannina Gaslini Children's Hospital, Genoa - Surgical risk factors used to predict adverse surgical outcome for neuroblastoma

Glenfield General Hospital, Leicester - Warm blood temperature improves efficacy of leukodepleting arterial line filter

Haukeland University Hospital, Bergen - Resectability of rectal cancers was still fixed after radiochemotherapy

Healthcare Costs - Guardian, Destiny Health bolster consumer-directed healthcare business

Healthcare Costs - Healthcare spending report demonstrates value of cost containment techniques

Helsinki University Hospital - Molecular adsorbent recycling system shows promise for treatment

HemoSense, Inc. - Agreement signed to distribute INRatio, use web-based patient management system

Home Healthcare - The hospital-at-home care model is safe and feasible for some

Hopital Albert Schweitzer, Deschapelles - Incidence of peripartum cardiomyopathy is higher in Haiti than U.S.

Hospital Universitario de La Princesa, Madrid - New findings in the area of HIV/AIDS pathogenesis detailed

INSERM, Lyon - Different patient population accounts for increased AIDS incidence in France

Idenix Pharmaceuticals, Inc. - Positive data reported from phase IIb trial of hepatitis C drug

Immune Disorders - Patients now surviving once-fatal X-linked agammaglobulinemia

Jeonbuk National University Hospital, Jeollabukdo - Ethylene glycol functions in asialoglycoprotein receptor targeted gene delivery

Kyoto University Hospital - Anticancer drugs regulate peptide transporter 1 in gastric cancer cells

Liverpool Hospital - Use of smaller guiding catheter doesn't reduce vascular complications

Maastricht University Hospital - Radiolabeled annexin A5 may be developed as a cell-death monitor